Pre- and Postoperative Nutrition in Head and Neck Cancer Patients
NCT ID: NCT03531190
Last Updated: 2019-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2018-05-10
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Nutritional Intervention in Head and Neck Cancer
NCT03971656
Supplementary Postoperative Parenteral Nutrition for Head and Neck Cancer Patients
NCT03042195
Nutritional Supplementation in Patients With no Signs of Malnutrition
NCT01894828
Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay
NCT01789073
Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer
NCT03261180
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nutritional supplement (Protein + MIX)
Patients are given: Nutritional Supplement of protein 2-3 times a day + MIX once daily for 35 days
Nutritional supplement (Protein + MIX)
Protein supplement as needed + 750 mg vitamin C, 15 g. arginine, 35 mg. zinc and two multivitamin tablets, by mouth every day for 35 days.
Nutritional supplement (Protein)
Nutritional Supplement of protein as needed 2-3 times a day for 35 days
Nutritional supplement (Protein)
Protein supplement as needed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutritional supplement (Protein + MIX)
Protein supplement as needed + 750 mg vitamin C, 15 g. arginine, 35 mg. zinc and two multivitamin tablets, by mouth every day for 35 days.
Nutritional supplement (Protein)
Protein supplement as needed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who understand written and oral Danish, and are able to give written consent
* Patients diagnosed with head and neck cancer, which are set for surgery
* Patients operated on the outside of the neck
Exclusion Criteria
* Not Authorized/not legal age (\<18 years)
* Pregnant and breastfeeding women
* Patients previously employed in the field of surgery within the last 5 years (prior years)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jens Rikardt Andersen
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens Rikardt R Andersen, MD,MPA
Role: PRINCIPAL_INVESTIGATOR
University of Copenhagen, Department of Nutrition, Exercise and Sports
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-17040654
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.